March 2022

Mayeta Clark 2015

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial

March 22, 2022

Background:┬áThere is a high risk of Plasmodium vivax recurrence in patients treated for Plasmodium falciparum malaria in co-endemic areas. Primaquine…

Read More

Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data

March 7, 2022

Background:┬áPlasmodium falciparum malaria is associated with anaemia-related morbidity, attributable to host, parasite and drug factors. We quantified the haematological response…

Read More

Quantification of the dynamics of antibody response to malaria to inform sero-surveillance in pregnant women

March 5, 2022

Background:┬áMalaria remains a major public health threat and tools sensitive to detect infections in low malaria transmission areas are needed…

Read More

Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity

March 1, 2022

Clinical studies have shown that adding a single 0.25 mg base/kg dose of primaquine to standard antimalarial regimens rapidly sterilizes…

Read More